| http://www.w3.org/ns/prov#value | - ???ConjuGon???s business strategy is to partner or sell drug candidates in its pipeline during Phase II human studies???, said Gary Greenwood, ConjuGon???s chairman and a founding partner of Rosetta Partners. ???Approval of the IND for ConjuGon???s lead product is a significant step forward both for this product and for the company as a whole.??? Rosetta Partners, based in Lake Forest, Illinois, i
|
